Access
To read this story in full you will need to login or make a payment (see right).
Scientific Correspondence
Nature 398, 671-672 (22 April 1999) | doi:10.1038/19439
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Gastrointestinal Pathologist
- Brigham and Women's Hospital
- Boston, MA
Organic Chemistry
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Antibacterial peptide from H. pylori
Katrin Pütsep, Carl-Ivar Brändén, Hans G. Boman & Staffan Normark
Abstract
Colonization of the human stomach by the bacterium Helicobacter pylori is a predisposing factor for gastrointestinal illnesses such as gastritis and peptic ulcers1. But most infections are asymptomatic, and it has recently been suggested that H. pylori may actually have beneficial effects on infected carriers who are heavily exposed to other gastrointestinal pathogens2. We find that H. pylori possesses antibacterial activity to which it is itself resistant. We have traced this activity to cecropin-like amino-terminal peptides derived from the ribosomal protein L1 (RpL1).
To read this story in full you will need to login or make a payment (see right).

